glp-1 and prednisone Is It Time for a New Algorithm for the Pharmacotherapy of Steroid-Induced Diabetes? GLP-1 receptor agonists and next-generation
Description
A szv- s rrendszer egszsge
7 Tirzepatide is a unimolecular, bifunctional peptide invented by Eli Lilly and Company (Indianapolis, IN, USA), which simultaneously activates GLP-1R and GIPR
however, it commonly leads to a rapid loss of residual renal function, potentially resulting in anuria even over short treatment intervals
Fang, Y
Ongoing support is available through the Omzo app and care team
